In the development of the mammalian intestine, Notch and Wnt/-catenin signals control stem cell maintenance and their differentiation into absorptive and secretory cells. Mechanisms that regulate differentiation of progenitors into the three secretory lineages, goblet, paneth or enteroendocrine cells, are not fully understood. Using conditional mutagenesis in mice, we observed that Shp2-mediated MAPK signaling determines the choice between paneth and goblet cell fates and also stem cells, which express the leucine-rich repeat-containing receptor 5 (Lgr5). 
Introduction
The intestinal epithelium of mammals consists of absorptive enterocytes and of three secretory cell types, paneth, goblet and enteroendocrine cells, which are continuously replenished from stem cells that reside in niches in the lower parts of the crypts (1, 2) . The secretory lineages differentiate from a common progenitor that emerges to occupy the +5 cell position above the stem cell niches (3) . Goblet and paneth cells continue to share similar characteristics, while enteroendocrine cells develop separately through a divergent mechanism. During differentiation, paneth cells move back to the base of the crypts and become interspersed between the stem cells, while the other cell types migrate into the villi (1, 2) . Paneth cells provide signals for the maintenance of stem cells, which are characterized by the expression of the stem cell marker Lgr5. Lgr5 is a receptor for R-spondins and participates in canonical Wnt signaling (4) . Lgr5+ stem cells are reduced but not depleted when paneth cells are lacking (5, 6) , which indicates that paneth cells are not the sole source of the signals that maintain stem cells.
Wnt/-catenin signaling, through cooperation of Wnt receptors and Lgr4/5 co-receptors, is essential in maintaining the intestinal epithelium, and plays important roles in the generation of Lgr5+ stem cells (1) . Canonical Wnt signaling also influences secretory cell lineages, since overexpression of the Wnt antagonist dickkopf1 (Dkk1) lead to a loss of all secretory cell types (7) . However, Wnt/-catenin signaling has different effects on the development of the three secretory cell types: paneth cells require Wnt and Lgr4 (8, 9) , high Wnt activity interferes with goblet cell differentiation (10) , while enteroendocrine progenitors are Wnt-independent (11) . This indicates that additional mechanisms come into play in the differentiation of the secretory lineages. One candidate might be MAPK signaling, because conditional expression of oncogenic K-ras resulted in intestinal hyperplasia and was accompanied by altered goblet and paneth cell numbers (12) .
The non-receptor tyrosine phosphatase Shp2 mediates growth factor and cytokine signals and can regulate the activity of the Ras/Mek1/MAPK and other signaling pathways in development and disease (13, 14) . In mice, a null mutation of Shp2 interfered with the expansion of the trophoblast cell lineage and led to implantation deficits (15) . Shp2 is also required for the development and maintenance of the nervous system, the kidney and other organs (13, 14, 16, 17) ; its role in the maintenance of the intestinal epithelium is not fully investigated. Heterozygous mutation of Shp2 in an Egfr mutant background resulted in the accumulation of desquamated intestinal epithelia (18) . Shp2 and the transcription factor Stat3 are activated through the interleukin/gp130 receptor; however, mutation of the Shp2-binding site in gp130 has no major effects on intestinal development. Instead, it enlarges the proximal small intestine in aging mice and protects intestines from dextran sulphate-induced colitis (19) .
Here we used mouse genetics to demonstrate that Shp2 and Mek1/MAPK signaling control the choice between goblet and paneth cell fates. Ablation of Shp2 promotes paneth cell expansion while reducing goblet cell formation. Conversely, activation of Mek1/MAPK promotes the generation of goblet cells at the expense of paneth cells. We provide evidence that Shp2/Mek1/MAPK-mediated regulation of Wnt/-catenin signaling is crucial for the lineage decision by which goblet and paneth cells differentiate from a common progenitor cell type.
Results

Shp2 is essential for goblet cell differentiation:
We aimed to assess the role of Shp2/MAPK signaling in cell fate determination of the intestine.
By conditional mutagenesis, we generated mutant mice that lacked Shp2 in the intestine using (16, 20) ). Remarkably, ablation of Shp2 strongly reduced goblet cell numbers in the small intestine and the colon, as assessed by alcian blue staining ( Fig.   1 A, B) . The intervention was accompanied by a drop in mRNAs of Spdef, Muc2 and Gob5, which are typically expressed in goblet cells (21) (22) (23) , as assessed by qRT-PCR ( Fig. 1 C, D) .
Immunohistochemical analysis (IHC) of Spdef and Gob5 proteins confirmed reduced goblet cell numbers ( Fig. S1 A, B, quantification on the right). The Shp2 mutant phenotype was mildly mosaic: goblet cell numbers were reduced in a pronounced manner in large areas that displayed high levels of Cre protein and loss of Shp2 expression ( Enteroendocrine cells were not affected by the loss of Shp2, as assessed by IHC for ChromagraninA ( Fig. S1 F, quantification on the right). The morphology of intestinal villi of Shp2 mutants was slightly aberrant; some villi appeared to be shortened or thickened ( Fig.1 A, upper right, Fig. S1 A-D, right). Shp2 mutants also developed diarrhea and anal bleeding, which are symptoms of severe colitis, and were growth-retarded (Fig. S1 G) . We observed a corresponding reduction in mRNA of Aquaporins 7 and 8 in the intestines of Shp2 mutants, as assessed by qRT-PCR (Fig. S1 H) . These genes are known to be downregulated in human and mouse colitis (24) .
The data thus show that the Shp2 mutation in the intestine results in goblet cell deficits and colitis.
Ablation of Shp2 induces premature differentiation of paneth cells and activates Wnt/-catenin signaling:
Differentiated paneth cells that produce lysozyme and matrilysin (MMP7) appear only after birth (25) and were thus rare in intestines of control mice at P6 (Fig. 2 A, left) . Shp2 mutants, however, exhibited a massive increase in paneth cells at this stage (Fig. 2 A, right, quantification in Fig. 2 B), which indeed appear only in Shp2-deficient crypts (Fig. S2 A, yellow arrow points to Shp2-deficient crypt with paneth cells, blue arrowhead points to a non-recombined crypt without paneth cells). The noted expansion of paneth cells potentially mimics an increase in canonical Wnt signals. Wnt signaling has been implicated in paneth cell differentiation (8) , and accordingly, administration of Wnt3a increases paneth cell numbers in intestinal organoid cultures (26) .
Increases of paneth cells were also noted after tamoxifen-induced ablation of Shp2 in intestinal organoids from villinCreERT2 mice, as assessed by IHC or qRT-PCR for lysozyme ( Fig. 2 C, Fig.   S2 B) . This led us to examine whether the effects of the Shp2 mutation and the enhanced paneth cell differentiation are mediated by activation of canonical Wnt signaling. We performed genomewide expression analyses on mutant and control intestines using Illumina microarrays (GSE50785), and then used gene set enrichment analysis to compare these with data previously obtained on Wnt/-catenin-dependent genes in the intestine (27, 28) . Shp2 mutant intestines exhibited a marked upregulation of Nol5a, Myc, and Cd44 and several other Wnt/-catenindependent genes (Fig. 2 D, Fig. S2 C) . Increases in the expression of Wnt3, the Wnt target gene Cd44, and genes encoding Lgr4 and the closely related Lgr5 were also noted in Shp2 mutant intestines, as confirmed by qRT-PCR (Fig. 2 E) . Thus, Wnt/-catenin signaling is indeed enhanced after Shp2 ablation in the murine small intestine.
Also upregulated in Shp2 mutants was the gene Lgr5, which is normally uniquely expressed in stem cells (1) . We used the Lgr5-IRES-GFP-CreERT allele to identify Lgr5+ stem cells by IHC for GFP (29) and observed an increase in their numbers in Shp2 mutant mice (Fig. 2 F) . This was confirmed by in situ hybridization for Olfm4, another marker of Lgr5+ stem cells ( 
Shp2 controls Erk1/2-MAPK signaling in the intestinal crypts:
In many cell types, Shp2 activates Mek1, which in turn phosphorylates Erk1/2. Immunohistological analysis of control intestines demonstrated high nuclear phospho-Erk1/2 levels in goblet cells as well in cells located in the lowest part of the villi and in the upper parts of the crypts; phosphoErk1/2 levels were strongly reduced in the Shp2 mutant ( Fig. 3 A, Insets) , reinforcing the notion that Shp2 might control goblet and paneth cell differentiation through the regulation of Mek1/MAPK signaling. To pursue this, we took advantage of a transgenic mouse strain that expresses a gain-of-function variant of Mek1 (Mek1DD) upon removal of a translation stop cassette through Cre-mediated recombination (Fig. S3 A) (32, 33) . Mek1DD expression could be activated by villinCre in the Shp2 mutant background. In the intestine of Mek1DD; Shp2 double mutants at P6, nuclear p-Erk1/2 levels were strongly elevated ( Fig. S3 B, right), but overall proliferation was not significantly changed, as assessed by Ki67 staining (Fig. S3 C, D) .
Remarkably, the Shp2-dependent reduction of goblet cells both in the small intestine and the colon was rescued in Mek1DD; Shp2 double mutants ( Fig. 3 B, right, Fig. S3 E) . The numbers of rescued goblet cells in the intestine were comparable to goblet cell numbers in control mice (Fig.   S3 F) . Further, paneth cells were strongly reduced in Mek1DD; Shp2 double mutants at P6 and P16, as shown by Lysozyme staining (Fig. 3 C, Fig. S3 G) . Loss of paneth cells was previously observed in mice that express an oncogenic variant of K-Ras, and suggested to be caused by increased Hes1 expression (12) . However, Hes1 expression was not significantly changed in Shp2 single and Mek1DD; Shp2 double mutants (Fig. S3 H) . Thus, in Mek1DD; Shp2 double mutant mice goblet cells are rescued, and this appears to occur at the expense of paneth cells.
This is reminiscent of the phenotype observed after overexpression of the Ets transcription factor
Spdef; Spdef overexpression promoted goblet cell differentiation at the expense of paneth cells (22) . In control mice, goblet and paneth cells produce the Ets transcription factor Spdef, as assessed by IHC (Fig. 3 B, marked by arrows on the left). In Shp2 mutants, Spdef production was observed in the few residual goblet cells (Fig. 3 B , located in villi) as well as in paneth cells (located in crypts, middle panel). In Mek1DD; Shp2 double mutants, the production of Spdef was limited to the rescued goblet cells in the villi (Fig. 3 B, right) . Apparently, Mek1 activity in intestinal epithelial cells does not change the cell type-specific expression pattern of Spdef. Overall, we conclude that Mek1/MAPK signaling regulates the choice between goblet and paneth cell differentiation.
The Shp2 mutation does not only affect goblet and paneth cell fates, but also increases the presumptive Lgr5+ stem cells (see above, Fig. 2 F) . We therefore analyzed stem cells in Mek1DD; Shp2 double mutants, and observed downregulated expression of Lgr5, Olfm4 and Ascl2 by in situ hybridization and qRT-PCR (Fig. 3 D, Fig. S3 I) . Thus, Shp2/MAPK signaling also controls the number of stem cells. The transcription factor Tcf4 activates Wnt/-catenin targets genes and is critical for the maintenance and differentiation of intestinal epithelia (34, 35) . Since mutation of the Tcf4 gene in the adult small intestine induced a paneth to goblet cell transition (35), we analyzed Tcf4 production in the small intestine by immunohistochemistry. Nuclear Tcf4 protein was observed throughout the entire crypt-villus axis, with the strongest levels in the crypts (Fig. S4 A) . Goblet cells in controls also showed strong nuclear Tcf4 (Fig. S4, inset a) . However, no difference in Tcf4 production was observed between control and Shp2 mutants (Fig. S4 A) . However, Tcf4 splice variants with different transcriptional capacities might be differentially produced (36) (Fig. 4 A, B) . Two major Tcf4 protein isoforms were produced in control organoids but remarkably, Shp2 mutant organoids showed reduced amounts of the shorter isoform, which was rescued by the Mek1DD allele (Fig. 4 B, the shorter Tcf4 isoform is marked by an arrow). The longer isoform at 70kDa is Tcf4E, which harbors a binding site for the transcription factor carboxy-terminal binding protein (CtBP) and an extended C-terminal domain including a C-clamp, which is a further DNA binding domain (37) . In contrast, the shorter Tcf4 band at 50kDa (arrow in Fig.4B ) corresponds to the Tcf4M and S isoforms, which lack the binding sites for CtBP and carry no or an incomplete C-clamp (37) . The Tcf4M and S isoforms can therefore bind to Wnt response elements on the DNA but lack the capacity of promoter activation, for instance of the Wnt target gene Axin2 (37) . The different amounts of the Tcf4 isoforms by changed MAPK signaling is regulated on the translational level, since the mRNAs for the Tcf4 isoforms were not altered between control and mutant organoids (Fig. S4 B) .
Moreover, in human HT29 colon cancer cells, pharmacological inhibition of MEK1/2 by the small molecule U0126 also produced reduced amounts of the shorter TCF4M/S isoforms in concentration and time-dependent manners (Fig. 4 C, Fig. S4 C, D) . Reduction of the TCF4M/S isoforms was rapid, starting already at 3h, and was significantly reduced at 6h of MEK1/2 inhibition (Fig. 4 D, S4 E) , at time-points when the large TCF4 isoform was not significantly altered.
Importantly, pharmacological inhibition of MEK1/2 by U0126 also rapidly increased the expression of the canonical Wnt target gene AXIN2, already at 3h (Fig. 4 E, left) . However, upregulation of the paneth cell differentiation marker Lysozyme occurred only after 24h of MEK1/2 inhibition (Fig.   4 E, right) . shRNA-mediated knockdown of SHP2 in HT29 cells did not affect MEK1/2 activity (Fig.   S4 F) , which is in line with the fact that HT29 cells harbor an oncogenic B-RAF mutation (38) that activates MAPK signaling downstream of SHP2. Furthermore, shSHP2 interference did not alter the expression of the TCF4 isoforms (Fig. S4 F) , indicating that the alterations of the TCF4M/S isoforms are regulated by MEK1/2 signaling and not via other SHP2-mediated events. Co-immunopreciptiation of TCF4 with -catenin from nuclear fractionations showed that the interaction of -catenin with TCF4E was persistent upon MEK1/2 inhibition (Fig. S4 G) . To pursue further the mechanism of the MEK1/2-dependent reduction of TCF4M/S proteins, we inhibited proteasome protein degradation with MG132. Remarkably, this inhibition prevented the MEK1/2-dependent reduction of the shorter TCF4M/S isoforms (Fig. 4 F, quantification in Fig. 4 G) , indicating that MEK1/2 activity protects the shorter isoforms from proteasomal degradation. In conclusion, MEK1/2 inhibition appears to affect canonical Wnt signaling by rapidly changing the relative abundance of the TCF4 isoforms, i.e., suppressing the transcriptionally inactive/inhibitory isoforms, while leaving the activating form unchanged. These data thus suggest that Shp2/Mek1/MAPK signaling regulates the choice between goblet and paneth cell fate by regulating Wnt/-catenin signaling through interfering with the protein stability of particular Tcf4 isoforms.
Discussion
Goblet and paneth cells represent two secretory cell types in the intestinal epithelium. Here we show that in mouse intestinal development, the tyrosine phosphatase Shp2 promotes the generation of goblet cells at the expense of paneth cells. Conditional Shp2 ablation in the intestine, which decreases MAPK signaling, reduces the numbers of goblet cells and increases the numbers of paneth cells. In contrast, sustained activation of MAPK signaling by the Mek1DD allele has the converse effects. Paneth and goblet cells express overlapping sets of genes (22, 39) , and cells with initially intermediary phenotypes have indeed been described (35, 40) . Paneth and goblet cells are thus closely related and originate from a common precursor (scheme in Fig.   S5 , left). The third secretory lineage, enteroendocrine cells, is generated independently of Shp2 and MAPK activity, and is believed to diverge from secretory precursors at an earlier stage of development (Fig. S5, left) (41) . Overall, our data thus show that the level of Shp2/MAPK signaling determines the choice between goblet and paneth cell fates.
We also found that Shp2/MAPK attenuates canonical Wnt signaling, which may mediate the effect of Shp2/MAPK on the goblet/paneth cell fate changes: goblet cells differentiate, when MAPK and Wnt activity are high and low, respectively, whereas paneth cells differentiate, when MAPK and Wnt signals are low and high, respectively (Fig. S5, left) . Our analysis of mutant intestinal organoid cultures and of HT29 colon cancer cells using pharmacological interference is supporting such a model and provides mechanistic insights: MAPK inhibition increases Wntcatenin signaling and promotes paneth cell characteristics, whereas high MAPK activity or inhibition of Wnt signaling favors goblet cell properties (Fig. S5, right) .
The Shp2 mutation also triggers colitis and reduced body weight, which are fully rescued by MAPK activation. Shp2/Mek1DD double mutant mice are viable and develop no diarrhea or anal bleeding. For function, Shp2 is recruited to several tyrosine kinase receptors and other cell surface receptors (13 increase of goblet cell numbers were also observed in intestines after conditional overexpression of oncogenic K-rasG12D (12) . In addition, K-rasG12D produced hyperplastic polyps and severely distorted crypt architecture, which we do not observe in the Mek1DD mutants. The loss of paneth cells was attributed to Ras-mediated expression of the transcription factor Hes1 (12) . In contrast,
we did not observe changes in Hes1 expression in Mek1DD or Shp2 mutants. In Ras mutant intestines, no effect on Wnt signaling has been reported (12) . In contrast, oncogenic Ras acted synergistically with canonical Wnt signaling in APC mutant intestines (45) . Apparently, oncogenic K-Ras controls larger sets of downstream signaling events than Shp2 and Mek1, which may explain the additional phenotypes.
We observed that Shp2/MAPK signaling affected canonical Wnt activity in the intestinal epithelium: high Shp2/MAPK activity decreased Wnt/-catenin signals and promoted goblet cell differentiation, whereas Shp2 ablation increased Wnt/-catenin activity and promoted paneth cell differentiation (Fig. S5, right) . Canonical Wnt signals downstream of MAPK thus appear to control the choice between goblet and paneth cell differentiation, as is also indicated by genetic analysis of Tcf4 (35) . A common secretory precursor has recently been located at the +5 position in small intestines (3) . Cells at the +5 position are believed to receive intermediary levels of Wnt/-catenin, and our data show that these cells also display intermediary MAPK activity. In contrast, highest canonical Wnt activity is observed at the base of the crypts (46), whereas MAPK signaling (as assessed by nuclear pErk1/2 distribution) is high in the upper part of the crypts. We therefore suggest that the balance between Wnt/-catenin and Shp2/MAPK activities controls the choice between goblet/paneth cell differentiation in these precursors.
To define mechanisms by which Shp2/MAPK exert a negative effect on Wnt/-catenin activity, we analyzed intestinal organoids genetically, and colon cancer cells using pharmacological inhibition.
We observed that Shp2 and MAPK signaling interfere with the production of Tcf4 isoforms. Tcf4 transcription factors are critical for the differentiation and maintenance of intestinal epithelia (34, 35) . Different variants of Tcf4 proteins exist that are generated from differentially spliced mRNAs, and exhibit different transcriptional activation capacities (36, 37) . The shorter isoform corresponds to Tcf4M/S, which lack the CtBP-binding and transactivation motifs (37) . In contrast, the longer Nuclei from HT29 cells were enriched as described before (48) followed by brief sonification, and co-immunoprecipitions were performed at 4°C with anti--catenin antibody (BDbioscience) and Protein-G-sepharose (GEhealthcare). Beads were washed four times with PBS/NP40 (0,1%), and immunoprecipitated proteins were analyzed by Western blotting. RNA was isolated from pieces of proximal small intestine, which was processed for gene profiling (Illumina) according to the manufacturer's protocol (Illumina total prep, Ambion, Life Technologies). Gene set enrichment analysis was performed using GESA software from the Broad Institute (27) .
Cells were cultured in DMEM supplemented with 10% FCS (Gibco) and treated with 10µM U0126
(Calbiochem) for 3h-24h or as indicated. Proteasomes were inhibited for 6h by 25µM of MG132 (Sigma) with or without 10µM U0126. Organoid culture (49) was performed with supplement from HEK293 cells, which overexpressed recombinant R-spondin1. The R-spondin1 plasmid was a gift of Christof Niehrs, Mainz. Tamoxifen-inducible Shp2 mutant organoids were split two days before treatment with 400nM 4-hydroxitamoxifen (4-OHT) (Sigma) for two consecutive days and were cultured for further 4 days. 
Figure legends
